84 related articles for article (PubMed ID: 20560287)
1. Antioxidant therapy for idiopathic pulmonary fibrosis. A promising therapeutic prospect.
Tomioka H
Sarcoidosis Vasc Diffuse Lung Dis; 2009 Jul; 26(2):83-4. PubMed ID: 20560287
[No Abstract] [Full Text] [Related]
2. Progress of Statin Therapy in the Treatment of Idiopathic Pulmonary Fibrosis.
Kou L; Kou P; Luo G; Wei S
Oxid Med Cell Longev; 2022; 2022():6197219. PubMed ID: 35345828
[TBL] [Abstract][Full Text] [Related]
3. The quest for the initial lesion in idiopathic pulmonary fibrosis: gene expression differences in IPF fibroblasts.
Eickelberg O; Laurent GJ
Am J Respir Cell Mol Biol; 2010 Jan; 42(1):1-2. PubMed ID: 20026648
[No Abstract] [Full Text] [Related]
4. The pathogenesis of bleomycin-induced lung injury in animals and its applicability to human idiopathic pulmonary fibrosis.
Williamson JD; Sadofsky LR; Hart SP
Exp Lung Res; 2015 Mar; 41(2):57-73. PubMed ID: 25514507
[TBL] [Abstract][Full Text] [Related]
5. An inhibitor of NADPH oxidase-4 attenuates established pulmonary fibrosis in a rodent disease model.
Jarman ER; Khambata VS; Cope C; Jones P; Roger J; Ye LY; Duggan N; Head D; Pearce A; Press NJ; Bellenie B; Sohal B; Jarai G
Am J Respir Cell Mol Biol; 2014 Jan; 50(1):158-69. PubMed ID: 23977848
[TBL] [Abstract][Full Text] [Related]
6. The definition of fibrogenic processes in fibroblastic foci of idiopathic pulmonary fibrosis based on morphometric quantification of extracellular matrices.
Yamashita M; Yamauchi K; Chiba R; Iwama N; Date F; Shibata N; Kumagai H; Risteli J; Sato S; Takahashi T; Ono M
Hum Pathol; 2009 Sep; 40(9):1278-87. PubMed ID: 19386353
[TBL] [Abstract][Full Text] [Related]
7. Statin Use, Lipids, and 3-Hydroxy-3-Methyl-Glutaryl Coenzyme A Reductase Inhibition on Risk of Idiopathic Pulmonary Fibrosis.
Zhao SS; Alton P; Rogers K; Hughes DM
Clin Ther; 2024 Jan; 46(1):79-81. PubMed ID: 37978012
[No Abstract] [Full Text] [Related]
8. Compromised peroxisomes in idiopathic pulmonary fibrosis, a vicious cycle inducing a higher fibrotic response via TGF-β signaling.
Oruqaj G; Karnati S; Vijayan V; Kotarkonda LK; Boateng E; Zhang W; Ruppert C; Günther A; Shi W; Baumgart-Vogt E
Proc Natl Acad Sci U S A; 2015 Apr; 112(16):E2048-57. PubMed ID: 25848047
[TBL] [Abstract][Full Text] [Related]
9. Aberrant expression and activity of histone deacetylases in sporadic idiopathic pulmonary fibrosis.
Korfei M; Skwarna S; Henneke I; MacKenzie B; Klymenko O; Saito S; Ruppert C; von der Beck D; Mahavadi P; Klepetko W; Bellusci S; Crestani B; Pullamsetti SS; Fink L; Seeger W; Krämer OH; Guenther A
Thorax; 2015 Nov; 70(11):1022-32. PubMed ID: 26359372
[TBL] [Abstract][Full Text] [Related]
10. Potential role of statin use in idiopathic pulmonary fibrosis.
Santana AN; Kairalla RA; Carvalho CR
Am J Respir Crit Care Med; 2008 May; 177(9):1048. PubMed ID: 18434336
[No Abstract] [Full Text] [Related]
11. Statin Use Is Associated with Reduced Mortality in Patients with Interstitial Lung Disease.
Vedel-Krogh S; Nielsen SF; Nordestgaard BG
PLoS One; 2015; 10(10):e0140571. PubMed ID: 26473476
[TBL] [Abstract][Full Text] [Related]
12. Hydrogen Sulfide: A Therapeutic Candidate for Fibrotic Disease?
Song K; Li Q; Yin XY; Lu Y; Liu CF; Hu LF
Oxid Med Cell Longev; 2015; 2015():458720. PubMed ID: 26078807
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary hypertension and idiopathic pulmonary fibrosis: a tale of angiogenesis, apoptosis, and growth factors.
Farkas L; Gauldie J; Voelkel NF; Kolb M
Am J Respir Cell Mol Biol; 2011 Jul; 45(1):1-15. PubMed ID: 21057104
[TBL] [Abstract][Full Text] [Related]
14. Epithelial stem cell exhaustion in the pathogenesis of idiopathic pulmonary fibrosis.
Chilosi M; Doglioni C; Murer B; Poletti V
Sarcoidosis Vasc Diffuse Lung Dis; 2010 Jul; 27(1):7-18. PubMed ID: 21086900
[TBL] [Abstract][Full Text] [Related]
15. [The research progress of fibroblast foci in idiopathic pulmonary fibrosis].
Kang XH; Zhang W
Zhonghua Jie He He Hu Xi Za Zhi; 2009 Mar; 32(3):203-5. PubMed ID: 19575940
[No Abstract] [Full Text] [Related]
16. Emerging therapeutic interventions for idiopathic pulmonary fibrosis.
Chakraborty S; Chopra P; Ambi SV; Dastidar SG; Ray A
Expert Opin Investig Drugs; 2014 Jul; 23(7):893-910. PubMed ID: 24766571
[TBL] [Abstract][Full Text] [Related]
17. Treating IPF--all or nothing? A PRO-CON debate.
Behr J; Kolb M; Cox G
Respirology; 2009 Nov; 14(8):1072-81. PubMed ID: 19909457
[TBL] [Abstract][Full Text] [Related]
18. Transcription factor GATA-6 is expressed in quiescent myofibroblasts in idiopathic pulmonary fibrosis.
Leppäranta O; Pulkkinen V; Koli K; Vähätalo R; Salmenkivi K; Kinnula VL; Heikinheimo M; Myllärniemi M
Am J Respir Cell Mol Biol; 2010 May; 42(5):626-32. PubMed ID: 19597127
[TBL] [Abstract][Full Text] [Related]
19. Metalloproteinases in idiopathic pulmonary fibrosis.
Dancer RC; Wood AM; Thickett DR
Eur Respir J; 2011 Dec; 38(6):1461-7. PubMed ID: 21700608
[TBL] [Abstract][Full Text] [Related]
20. Regulatory watch : First drug for idiopathic pulmonary fibrosis approved in Japan.
Nat Rev Drug Discov; 2008 Dec; 7(12):966-7. PubMed ID: 19043442
[No Abstract] [Full Text] [Related]
[Next] [New Search]
